Results 151 to 160 of about 14,309 (181)

Breakthrough during recombinant interferon alfa therapy in patients with chronic Hepatitis C virus infection: Prevalence, etiology, and management

Hepatology, 1995
Alberto Piperno, Giuseppe Mancia, F Dianzani   +2 more
exaly  

Case report of interferon alfa therapy for multiple myeloma during pregnancy

American Journal of Obstetrics and Gynecology, 1995
Philip J Disaia, P J Disaia
exaly  

Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial

Lancet, The, 2010
John Royston, Poulam Patel, Mahesh Parmar   +2 more
exaly  

INTERFERON ALFA

2014
openaire   +1 more source

Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C

Journal of Hepatology, 1997
Antonio Solinas, Piero Luigi Almasio, Giuseppe Realdi   +2 more
exaly  

Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases

British Journal of Dermatology, 2002
Marie Beylot-Barry, M S Doutre
exaly  

Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C

Journal of Hepatology, 2002
Michael Peter Manns, Markus Cornberg, Thomas Berg   +2 more
exaly  

Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)

Annals of Oncology, 2008
Claus Garbe, Reinhard Dummer, Ulrike Leiter   +2 more
exaly  

Interferon Alfa and Autoimmunity

Southern Medical Journal, 1996
openaire   +1 more source

Safety and Antiviral Activity of Albinterferon Alfa-2b in Prior Interferon Nonresponders With Chronic Hepatitis C

Clinical Gastroenterology and Hepatology, 2009
David Nelson, Gary L Davis, Erik Pulkstenis   +2 more
exaly